cbdMD, Inc.
Close on Oct 19, 2026
- Market cap
- $3.70M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q4 FY2025 Ended Sep 30, 2025 | Nov 25, 2025 | During market hours | – | – | – |
| Q3 FY2021 Ended Jun 30, 2021 | Aug 12, 2021 | During market hours | – | – | – |
| Q2 FY2021 Ended Mar 31, 2021 | May 12, 2021 | During market hours | – | – | – |
| Q4 FY2020 Ended Sep 30, 2020 | Oct 14, 2020 | Before market open | – | – | – |
| Q3 FY2020 Ended Jun 30, 2020 | Aug 4, 2020 | Before market open | – | – | – |
| Q2 FY2020 Ended Mar 31, 2020 | Apr 6, 2020 | Before market open | – | – | – |
| Q2 FY2019 Ended Mar 31, 2019 | May 10, 2019 | During market hours | – | – | – |
| Q1 FY2019 Ended Dec 31, 2018 | Feb 15, 2019 | Before market open | – | – | – |
| Q4 FY2018 Ended Sep 30, 2018 | Dec 13, 2018 | Before market open | – | – | – |
Press releases
Announcements cbdMD filed with the SEC
cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women ’ s Beauty, Weight Loss and Longevity Wellness
Material agreement · Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
cbdMD, Inc. Regains Compliance with NYSE American Listing Standards
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
cbdMD Reports Preliminary Unaudited Fourth Quarter and Fiscal 2025 Results
Results of operations · EX-99.1 to Form 8-K
cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting
Shareholder vote results · Other events · EX-99.1 to Form 8-K
cbdMD Announces It has Fully Satisfied its Notes
Other events · EX-99.1 to Form 8-K
cbdMD Announces Additional Conversions of its Convertible Notes
Other events · EX-99.1 to Form 8-K
cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard
Listing notice · Other events · EX-99.1 to Form 8-K
cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American
Listing notice · Other events · EX-99.1 to Form 8-K
cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Listing notice · Other events · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
cbdMD Announces Cancellation of Special Meeting
Other events · EX-99.1 to Form 8-K
cbdMD Announces Adjournment of Special Meeting
Other events · EX-99.1 to Form 8-K
cbdMD, Inc. Suspends Monthly Dividend Payment on its
Other events · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
cbdMD Announces Proposed Public Offering of Common Stock
Material agreement · Other events · EX-99.1 to Form 8-K
cbdMD Announces Pricing of $2.8 Million Underwritten Public Offering of Common Stock
Material agreement · Other events · EX-99.2 to Form 8-K
cbdMD Announces Closing of $2.8 Million Underwritten Public Offering of Common Stock
Material agreement · Other events · EX-99.3 to Form 8-K